BDBM604053 US11660293, Example 158::US11660293, Example 159::US11660293, Example 160

SMILES Cc1ccc(-n2nccn2)c(C(=O)N2C3CC(C3)[C@@H](C)C2CNc2cnc3ccccc3n2)n1

InChI Key InChIKey=UZPPFCJPRSHSQF-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 604053   

TargetOrexin/Hypocretin receptor type 1(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  2.09nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  3.98nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  145nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  1.05E+3nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  1.82E+3nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent

TargetOrexin receptor type 2(Human)
Chronos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 604053BDBM604053(US11660293, Example 158 | US11660293, Example 159 ...)
Affinity DataKi:  2.57E+4nMAssay Description:CHO cells stably transfected with human Orexin type 1 receptors (CHO-hOX1) or HEK-293 cells transiently transfected with human Orexin type 2 receptor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2023
Entry Details
US Patent